The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.

Abu Lila, Amr S; Kiwada, Hiroshi; Ishida, Tatsuhiro

Abu Lila, Amr S; Kiwada, Hiroshi; Ishida, Tatsuhiro.

Affiliation

Abu Lila AS; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Kiwada H; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan.
Ishida T; Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima; 1-78-1, Sho-machi, Tokushima 770-8505, Japan. Electronic address: ishida@tokushima-u.ac.jp.

J Control Release ; 172(1): 38-47, 2013 Nov 28.

Article de En | MEDLINE | ID: mdl-23933235

Sujet(s)
Mots clés

Accelerated blood clearance (ABC) phenomenon; Anti-PEG IgM; Polyethylene glycol(PEG); Repeated administration; Splenic B cells

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Polyéthylène glycols / Immunoglobuline M / Liposomes Limites: Animals / Humans Langue: En Journal: J Control Release Sujet du journal: FARMACOLOGIA Année: 2013 Type de document: Article Pays d'affiliation: Égypte Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google